Skip Navigation


Carcinogenesis Advance Access originally published online on July 13, 2006
Carcinogenesis 2007 28(2):259-266; doi:10.1093/carcin/bgl122
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/2/259    most recent
bgl122v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kwak, H.-I.
Right arrow Articles by Porter, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwak, H.-I.
Right arrow Articles by Porter, W. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Inhibition of breast cancer growth and invasion by single-minded 2s

Hyeong-Il Kwak1, Tanya Gustafson1, Richard P. Metz1, Brian Laffin1, Pepper Schedin2 and Weston W. Porter1,*

1 Department of Integrated Biosciences, College of Veterinary Medicine Texas A&M University, College Station, TX 77843-4458, USA
2 Division of Medical Oncology, University of Colorado Health Sciences Center CO, USA

*To whom correspondence and requests for reprints should be addressed. Tel: +979 845 0733; Fax: +979 862 4929; Email: wporter{at}cvm.tamu.edu

Single-minded 2 (SIM2) is a member of the bHLH-PAS family of transcription factors. SIM2 was initially identified by positional cloning on chromosome 21 and is thought to contribute to the etiology of trisomy-21 [Down syndrome (DS)]. In addition to the physical and mental deficiencies associated with this genetic disease, it has become apparent that women with DS are 10–25times less likely to die from breast cancer in comparison with age-matched normal populations. This is thought to be a result of gene dosage effect of tumor suppressor genes on chromosome 21. Here, we report that a splice variant of SIM2, SIM2 short (SIM2s), is differentially expressed in normal breast and breast cancer-derived cell lines and is downregulated in human breast cancer samples. Re-establishment of SIM2s in MDA-MB-435 breast cancer cells significantly reduced proliferation, anchorage-independent growth and invasive potential. Consistent with its role as a transcriptional repressor, SIM2s directly decreased expression of matrix metalloprotease-3, a known mediator of breast cancer metastasis. These results suggest that SIM2s has breast tumor suppressive activity.

Abbreviations: bHLH, basic helix–loop–helix; CAV1, caveolin-1; ChIP, chromatin immunoprecipitation; DS, Down syndrome; ECM, extracellular matrix; MMP, matrix metalloproteases; PAS, Per-Arnt-SIM; PMA, phorbol 12-myristate 13-acetate; RT–PCR, reverse transcription–polymerase chain reaction; SE, standard error; SIM2, single-minded 2; SIM2s, SIM2 short

Received March 1, 2006; revised June 26, 2006; accepted June 30, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. Woods, A. Farrall, C. Procko, and M. L. Whitelaw
The bHLH/Per-Arnt-Sim transcription factor SIM2 regulates muscle transcript myomesin2 via a novel, non-canonical E-box sequence
Nucleic Acids Res., June 1, 2008; 36(11): 3716 - 3727.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.